Uses
Meclizine hydrochloride is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.
Source: US FDA prescribing information
Molecule
Meclizine
Also known as meclizine hydrochloride
Available on request
- Presentations
- 4
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Meclizine is an antiemetic indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. It is available as tablets and chewable tablets for oral use. MedsAcross supplies Meclizine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Antiemetic, Emesis Suppression
- US FDA first approval
- 14 February 1957
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Oral
- Dosage forms
- Tablet, Chewable tablet
- Identifiers
- UNII HDP7W44CIORxCUI 82041CAS 31884-77-2Q27279880
Clinical information
From the regulator-approved product information. Each section names its source.
How it works
The precise mechanism by which meclizine exerts its therapeutic effect is unknown but is presumed to involve antagonism of the histamine H1 receptor.
Source: US FDA prescribing information
Dosing overview
Recommended dosage: 25 mg to 100 mg daily, in divided doses. Tablets: Swallow whole. Chewable Tablets: Must be chewed or crushed before swallowing, do not swallow whole.
Source: US FDA prescribing information
Contraindications
Meclizine hydrochloride is contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients. Meclizine hydrochloride is contraindicated in patients with hypersensitivity to meclizine or any of the inactive ingredients.
Source: US FDA prescribing information
Warnings and precautions
May cause drowsiness: Use caution when driving a car or operating dangerous machinery. Potential anticholinergic action: this drug should be prescribed with care to patients with a history of asthma, glaucoma, or enlargement of the prostate gland.
Source: US FDA prescribing information
Side effects
The following adverse reactions associated with the use of meclizine hydrochloride were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported. Common adverse reactions are anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting.
Source: US FDA prescribing information
Interactions
Coadministration of meclizine hydrochloride with other CNS depressants, including alcohol, may result in increased CNS depression. CYP2D6 inhibitors: As meclizine is metabolized by CYP2D6, there is a potential for drug-drug interactions between meclizine hydrochloride and CYP2D6 inhibitors.
Source: US FDA prescribing information
Storage
Store at 20 o C to 25 o C (68 o F to 77 o F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
4 presentations of Meclizine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Meclizine 25 mg tabletOralGeneric name | — | US FDA | Available on request |
| Meclizine 12.5 mg tabletOralGeneric name | — | US FDA | Available on request |
| Meclizine 50 mg tabletOralGeneric name | — | US FDA | Available on request |
| Meclizine 25 mg chewable tabletOralGeneric name | — | US FDA | Available on request |
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 14 February 1957 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Meclizine available for export from India?
Yes, on request. MedsAcross lists 4 presentations of Meclizine and sources them for licensed hospitals, importers and physicians against valid import documents.
Is Meclizine approved by the US FDA?
Yes. The US FDA first approved Meclizine on 14 February 1957, according to Drugs@FDA.
Does Meclizine need cold chain shipping?
No listed presentation of Meclizine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Meclizine Hydrochloride prescribing information (Rising Pharma Holdings). U.S. National Library of Medicine, DailyMed. Retrieved 2 June 2025
Request Meclizine for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.